Barcelona Alzheimer Treatment & Research Center

2014 BAN2401-G000-201

DENOMINACIÓN : A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study To Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease
CÓDIGO DE PROTOCOLO: BAN2401-G000-201
PROMOTOR: EISAI
FASE: II
INDICACIÓN CLÍNICA: a-MCI/Prod AD
INICIO: 05/2014
FINAL: activo

Deja un comentario